CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 61,864 enrolled
Drug / intervention
Does not apply +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01322633
NCT01322633N/ACompleted

Long-Term Prospective Observational Study of the Risk of Cancer Among Pantoprazole Users

Pfizer·observational·Posted Mar 24, 2011·Updated Feb 20, 2014

In Brief

An observational study evaluating Does not apply for Esophagitis. Completed, enrolled 61,864 participants.

Detailed Summary

The primary objective is to assess whether the risk of gastric cancer is increased in pantoprazole users compared to users of other proton pump inhibitors.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsEsophagitis
Countries--
Collaborators--

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 24, 2011
Enrollment StartJul 1, 2004
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 8.7 yearsPosted 15.3 years ago

Interventions

Does not applyother

This is a non-interventional study, therefore the intervention type / name do not apply.

Does not applyother

This is a non-interventional study, therefore the intervention type / name do not apply.